Associations of Metabolic Syndrome with Glaucoma in Korean - Based on the Korean National Health and Nutrition Examination Survey 2005, 2007-9, 2010

한국인의 대사증후군과 녹내장 간의 상관관계 -2005, 2007-9, 2010국민건강영양조사 이용

  • Park, Sang Shin (Dept. of Veterinary Integrative Biosciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University) ;
  • Kim, Taehun (Graduate School of Public Health and Institute of Health and Environment, Seoul National University) ;
  • Pak, Yun-Suk (Graduate School of Public Health and Institute of Health and Environment, Seoul National University) ;
  • Lee, Sang-Yoon (Dept. of Preventive Medicine, Kangwon National University) ;
  • Lee, Hae Jung (Nutrition Policy Team, Korea Health Industry Development Institute) ;
  • Lee, Eun-Hee (Dept. of Visual Optics and Graduate School of Health Science, Far East University)
  • 박상신 ;
  • 김태훈 (서울대학교 보건대학원 및 보건환경연구소) ;
  • 박윤숙 (서울대학교 보건대학원 및 보건환경연구소) ;
  • 이상윤 (강원대학교 의과대학 예방의학교실) ;
  • 이해정 (한국보건산업진흥원 영양정책팀) ;
  • 이은희 (극동대학교 안경광학과 및 보건과학대학원)
  • Received : 2012.05.02
  • Accepted : 2012.06.16
  • Published : 2012.06.30

Abstract

Purpose: This study was conducted to assess the association of metabolic syndrome and its components with glaucoma. Methods: We investigated the associations of metabolic syndrome and its components (abdominal obesity, impaired fasting glucose, high blood pressure, and dyslipidemia) with glaucoma using data from 19,162 adults aged 40 or above among the Korean National Health and Nutrition Examination Survey III (2005), IV (2007-9), V (2010). The logistic regression analysis was used for assessing those associations after adjusting demographic, lifestyle, and social economic status and for assessing the association of metabolic medication intakes with glaucoma risks. Results: After adjusting for age and sex, the risk of glaucoma was significantly higher in the subjects with impaired fasting glucose(Odds Ratio (95% confidence interval): 1.78 (1.25, 2.53)) and metabolic syndrome (1.45 (1.01, 2.08)) than subjects without those. These associations increased when additional adjusting for smoking, alcohol use, regular physical activity, income, education status(impaired fasting glucose: 1.89 (1.29, 2.77), metabolic syndrome: 1.52 (1.03, 2.25)). Glaucoma prevalence was borderline significantly increased according to the number of metabolic abnormalities(age and sex adjusted p for trend = 0.055). Use of antihypertensive medication was significantly associated with the risk of glaucoma. Conclusions: Metabolic syndrome and impaired fasting glucose were significantly associated with the increased glaucoma risk. Use of antihypertensive medication was also significantly associated with the increased glaucoma risk.

목적: 본 연구는 녹내장과 대사증후군, 그리고 구성요소간의 상관성을 평가하기 위해 수행되었다. 방법: 제 3기(2005), 4기(2007-9), 5기(2010) 국민건강영양조사 자료에서 40세 이상 19,162 명을 대상으로 녹내장과 대사증후군, 그리고 구성요소(복부비만, 공복혈당장애, 높은 혈압, 이상지질혈증) 간의 연관성을 조사하였다. 로지스틱회귀분석을 통하여 인구학적, 생활방식 그리고 사회경제적 요인을 보정한 후 연관성을 평가하였으며, 녹내장의 위험과 대사약물복용간의 연관성을 평가하였다. 결과: 성별 및 연령을 보정한 로지스틱 회귀분석에서, 공복혈당장애(odds ratio (95% Confidence Interval): 1.78 (1.25, 2.53)) 및 대사증후군(1.45 (1.01, 2.08))이 있는 연구대상자가 그렇지 않은 연구대상자에 비해 유의하게 높은 녹내장 교차비를 보였고, 추가적으로 흡연, 음주, 규칙적 운동, 소득, 교육수준을 보정하였을 때 교차비는 더욱 증가하는 것으로 나타났다(공복혈당장애: 1.89 (1.29, 2.77), 대사증후군: 1.52 (1.03, 2.25)). 또한, 연구대상자가 가지고 있는 이상 대사증후군 요소의 수에 따른 녹내장의 유병률 증가는 경계적 유의성(borderline significant: age and sex adjusted p for trend = 0.055)을 보였다. 고혈압 치료제의 사용 역시 녹내장의 위험과 유의한 상관관계가 있었다. 결론: 대사증후군 및 공복혈당장애는 녹내장과 유의한 상관관계가 있었고, 고혈압 치료제 사용 역시 녹내장과 유의한 상관관계가 있었다.

Keywords

References

  1. Bonomi L, Marchini G, Marraffa M, Bernardi P, De Franco I, Perfetti S, Varotto A. Tenna V. Prevalence of glaucoma and intraocular pressure distribution in a defined population. The Egna-Neumarkt Study. Ophthalmology. 1998;105(2):209-215. https://doi.org/10.1016/S0161-6420(98)92665-3
  2. Levene RZ. Low tension glaucoma: a critical review and new material. Surv Ophthalmol. 1980;24(6):621-664. https://doi.org/10.1016/0039-6257(80)90123-X
  3. Resnikoff S, Pascolini D, Etya'ale D, Kocur I, Pararajasegaram R, Pokharel GP, Mariotti SP. Global data on visual impairment in the year 2002. Bull WHO. 2004;82(11):844-851.
  4. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90(3):262-267. https://doi.org/10.1136/bjo.2005.081224
  5. Zang EA, Wynder EL. The association between body mass index and the relative frequencies of diseases in a sample of hospitalized patients. Nutr Cancer. 1994;21(3):247-261. https://doi.org/10.1080/01635589409514323
  6. Newman-Casey PA, Talwar N, Nan B, Musch DC, Stein JD. The relationship between components of metabolic syndrome and open-angle glaucoma. Ophthalmology. 2011;118(7):1318-1326.
  7. Kahn HA, Milton RC. Alternative definitions of openangle glaucoma. Effect on prevalence and associations in the Framingham eye study. Arch Ophthalmol. 1980;98(12):2172-2177. https://doi.org/10.1001/archopht.1980.01020041024003
  8. Klein BE, Klein R, Jensen SC. Open-angle glaucoma and older-onset diabetes. The Beaver Dam Eye Study. Ophthalmology. 1994;101(7):1173-1177.
  9. Mitchell P, Smith W, Chey T, Healey PR. Open-angle glaucoma and diabetes: the Blue Mountains eye study, Australia. Ophthalmology. 1997;104(4):712-718. https://doi.org/10.1016/S0161-6420(97)30247-4
  10. Chopra V, Varma R, Francis BA, Wu J, Torres M, Azen SP. Type 2 diabetes mellitus and the risk of open-angle glaucoma the Los Angeles Latino Eye Study. Ophthalmology. 2008;115(2):227-232. https://doi.org/10.1016/j.ophtha.2007.04.049
  11. Pasquale LR, Kang JH, Manson JE, Willett WC, Rosner BA, Hankinson SE. Prospective study of type 2 diabetes mellitus and risk of primary open-angle glaucoma in women. Ophthalmology. 2006;113(7):1081-1086. https://doi.org/10.1016/j.ophtha.2006.01.066
  12. Bonovas S, Peponis V, Filioussi K, Diabetes mellitus as a risk factor for primary open-angle glaucoma: a meta-analysis. Diabet Med. 2004;21(6):609-614. https://doi.org/10.1111/j.1464-5491.2004.01173.x
  13. Meigs JB. Definitions and mechanisms of the metabolic syndrome. Current Opinion in Endocrinology Diabetes and Obesity. 2006;13(2):103.
  14. Foreyt JP. Need for lifestyle intervention: how to begin. Am. J. Cardiol. 2005;96(4A):11E-14E.
  15. Tan GS, Wong TY, Fong CW, Aung T. Diabetes, metabolic abnormalities, and glaucoma. Arch Ophthalmol. 2009;127(10):1354-1361. https://doi.org/10.1001/archophthalmol.2009.268
  16. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA. Fruchart JC, James WP, Loria CM, Smith SC Jr. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640-1645. https://doi.org/10.1161/CIRCULATIONAHA.109.192644
  17. Oh K, Lee J, Lee B, Kweon S, Lee Y, Kim Y. Plan and Operation of the 4th Korea National Health and Nutrition Examination Survey (KNHANES IV). Korean J Epidemiol. 2007;29(2):139-145.
  18. Lee SY, Park HS, Kim DJ, Han JH, Kim SM, Cho GJ, Kim DY, Kwon HS, Kim SR, Lee CB, Oh SJ, Park CY, Yoo HJ. Appropriate waist circumference cutoff points for central obesity in Korean adults. Diabetes Res Clin Pract. 2007;75(1):72-80. https://doi.org/10.1016/j.diabres.2006.04.013
  19. Oh SW, Lee S, Park C, Kim DJ. Elevated intraocular pressure is associated with insulin resistance and metabolic syndrome. Diabetes Metab Res Rev. 2005;21(5):434-440. https://doi.org/10.1002/dmrr.529
  20. Park SS, Lee EH, Jargal G, Paek D, Cho SI. The distribution of intraocular pressure and its association with metabolic syndrome in a community. J Prev Med Public Health. 2010;43(2):125-130. https://doi.org/10.3961/jpmph.2010.43.2.125
  21. Imai K, Hamaguchi M, Mori K, Takeda N, Fukui M, Kato T, Kawahito Y, Kinoshita S, Kojima T. Metabolic syndrome as a risk factor for high-ocular tension. Int J Obes (Lond). 2010;34(7):1209-1217. https://doi.org/10.1038/ijo.2010.32
  22. Kim JH, Kang SY, Kim NR, Lee ES, Hong S, Seong GJ, Hong YJ, Kim CY. Prevalence and characteristics of glaucoma among Korean adults. Korean J Ophthalmol. 2011;25(2):110-115. https://doi.org/10.3341/kjo.2011.25.2.110
  23. Leske MC, Connell AM, Wu SY, Hyman LG, Schachat AP. Risk factors for open-angle glaucoma. The Barbados Eye Study. Arch Ophthalmol. 1995;113(7):918-924. https://doi.org/10.1001/archopht.1995.01100070092031
  24. Wormald RP, Basauri E, Wright LA, Evans JR. The African Caribbean Eye Survey: risk factors for glaucoma in a sample of African Caribbean people living in London. Eye (Lond). 1994;8(Pt 3):315-320. https://doi.org/10.1038/eye.1994.64
  25. Szaflik JP, Rusin P, Zaleska-Zmijewska A, Kowalski M, Majsterek I, Szaflik J. Reactive oxygen species promote localized DNA damage in glaucoma-iris tissues of elderly patients vulnerable to diabetic injury. Mutat Res. 2010; 697(1-2):19-23. https://doi.org/10.1016/j.mrgentox.2010.02.003
  26. De Castro DK, Punjabi OS, Bostrom AG, Stamper RL, Lietman TM, Ray K, Lin SC. Effect of statin drugs and aspirin on progression in open-angle glaucoma suspects using confocal scanning laser ophthalmoscopy. Clin Experiment Ophthalmol. 2007;35(6):506-513. https://doi.org/10.1111/j.1442-9071.2007.01529.x
  27. McGwin G, Jr McNeal S, Owsley C, Girkin C, Epstein D, Lee PP. Statins and other cholesterol-lowering medications and the presence of glaucoma. Arch Ophthalmol. 2004;122(6):822-826. https://doi.org/10.1001/archopht.122.6.822
  28. Hennis A, Wu SY, Nemesure B, Leske MC. Hypertension, diabetes, and longitudinal changes in intraocular pressure. Ophthalmology. 2003;110(5):908-914. https://doi.org/10.1016/S0161-6420(03)00075-7
  29. Mapstone R, Clark CV. Prevalence of diabetes in glaucoma. Br Med J (Clin Res Ed). 1985;291(6488):93-95. https://doi.org/10.1136/bmj.291.6488.93
  30. Wu SY, Leske MC. Associations with intraocular pressure in the Barbados Eye Study. Arch Ophthalmol. 1997;115(12):1572-1576. https://doi.org/10.1001/archopht.1997.01100160742012
  31. Owen CG, Carey IM, Shah S, de Wilde S, Wormald R, Whincup PH, Cook DG Hypotensive medication, statins, and the risk of glaucoma. Invest Ophthalmol Vis Sci. 2010;51(7):3524-3530. https://doi.org/10.1167/iovs.09-4821
  32. Korea Centers for Disease Control and Prevention, 2009: Korea Health Statistics 2008: Korea National Health and Nutrition Examination Survey (KNHANES IV-2). Korean Centers for Disease Control and Prevention, Seoul: 2009.